This is a demo store. No orders will be fulfilled.

In Vitro Diagnostics (IVD)

  1. 08 Jun 2018  |  North America  |  Market Research

    US Cardiac Troponin Diagnostics Market, Forecast to 2021

    High Prevalence of Heart Disease Propels Market Growth

    Cardiac troponins help to diagnose nearly two-thirds of the patients in the diagnosis Acute Coronary Syndrome (ACS) who are missed out by Echocardiogram (ECG). ECG can detect only one-third of the patients with persistent ST-segment Elevation (STEMI), whereas cardiac troponins can distinguish patients without ST-segment elevation (NSTEACS; non-ST s...

    $4,950.00
  2. 25 May 2018  |  Europe  |  Market Research

    Western European Cardiac Troponin Diagnostics Market, Forecast to 2021

    Emerging Biomarkers Disrupt and Spur Growth in the Heart Disease Segment

    Cardiac troponins have now become the gold standard for early diagnosis of acute myocardial infarction, making them indispensable for clinical diagnosis of Acute Coronary Syndrome (ACS). Cardiac troponins play a key role in minimizing hospital stays and reducing admission rate which are the biggest contributors to overall healthcare expenditure. Fo...

    $3,000.00
  3. 21 Dec 2017  |  North America  |  Market Research

    Strategic Insight into the Global Women’s Oncology Diagnostics Market, 2017

    Surge in Adoption of Next Generation Sequencing (NGS) Solutions for Predictive Diagnosis Transforms the IVD Testing Landscape

    Across the world, women live longer than men. The reason behind the difference between male and female life expectancy is unclear, but it seems related partially to biological advantages and partially to environmental and behavioral factors. Even though women outlive men, they are more prone to suffering from ill health and other age-related diseas...

    $1,500.00
  4. 21 Dec 2017  |  North America  |  Market Research

    Strategic Insight into the Global Women’s Urology Diagnostics Market, 2017

    Growth Spurred by Simple and Accurate Point of Care (POC) Testing at Home for Urological Conditions such as Nephrolithiasis and Urinary Tract Infections (UTIs)

    Across the world, women live longer than men. The reason behind the difference between male and female life expectancy is unclear, but it seems related partially to biological advantages and partially to environmental and behavioral factors. Even though women outlive men, they are more prone to suffering from ill health and other age-related diseas...

    $1,500.00
  5. 20 Dec 2017  |  North America  |  Market Research

    Strategic Insight into the Global Women’s Cardiology Diagnostics Market, 2017

    Integrated Devices and User-friendly Cardiac Monitoring Products Focused on Home Care Offer New Growth Opportunities

    Across the world, women live longer than men. The reason behind the difference between male and female life expectancy is unclear, but it seems related partially to biological advantages and partially to environmental and behavioral factors. Even though women outlive men, they are more prone to suffering from ill health and other age-related diseas...

    $1,500.00
  6. 30 Nov 2017  |  Europe  |  Market Research

    Growth Opportunities in European Prenatal Genetic Testing Market, Forecast to 2021

    Non-invasive Prenatal Testing (NIPT) Driven by the Adoption of Next Generation Sequencing (NGS) Techniques for Screening is Driving Market Growth

    Prenatal genetic tests are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, 13 and carrier screens. They are gaining momentum in EU due to enhanced assay outcomes through non-invasive methodologies using next generation sequencing (NGS) techniques, increasing number of women choosing to undergo pregnancy at an advanc...

    $3,000.00
  7. 25 Sep 2017  |  North America  |  Market Research

    2017 Customer Attitudes and Adoption Plans of Digital Pathology Technologies

    A Voice of Customer Study to Compare Trends Between Current and Potential Adopters of Digital Pathology Platforms

    A digital pathology end-user research was conducted to identify trends and developments in the field of digital pathology. The survey sought to collect the key information on usage and adoption and compare the perceptions of current and potential adopters of this technology. For the survey, lab managers and pathologists of pathology facilities we...

    $4,950.00
  8. 21 Jul 2017  |  North America  |  Market Research

    Growth Opportunities in the US Prenatal Genetic Testing Market, Forecast to 2021

    Rising Maternal Age, Improved Screening Algorithms Catering to Healthcare Payer Requirements, and Exploration of New Business Models Will Drive Market

    Prenatal genetic tests, which are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, and 13, and carrier screens, are gaining momentum in the United States due to enhanced assay outcomes through non-invasive methodologies, increased popularity through social media channels, and the growing number of women choosing to u...

    $4,950.00
  9. 15 Nov 2016  |  North America  |  Market Research

    Healthcare 2020—Business Model Transformation Guidebook

    Exploring New Models for Monetizing Services and Solutions

    Healthcare as an industry is entering a phase of rapid transformation. Digitization of products, services, and commerce models are democratizing current healthcare systems and unlocking new values by displacing high-cost gatekeepers and previously inaccessible segments. Around 80% of the business models in 2025 will be driven by platform-based heal...

    $4,950.00
  10. 12 Sep 2016  |  North America  |  Market Research

    Price Point Analysis for Laboratory Developed Tests (LDTs) and FDA Regulated Tests

    Discover the Perfect Assay Price Point to Remain Competitive

    The main objective of this research is to estimate test volumes and unit prices for a wide variety of LDTs (genetic) and a few high volume FDA tests for selective therapeutic areas. The tests are categorized by their intended uses across the diagnostic spectrum (risk assessment, screening, diagnosis, staging and prognosis, therapy selection, therap...

    $1,500.00